A VR Intervention for Promoting Prosocial Behavior and Well-being in Youth
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jun 10, 2024
Trial Information
Current as of November 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new virtual reality (VR) program designed to help young people develop positive social behaviors and improve their well-being as they transition from high school to college. The program uses fun, game-like elements to engage participants, making it easier for them to learn how to connect with others and feel better overall. The trial is not yet recruiting participants, but it aims to include youth aged 15 to 19 who are currently in their final year of secondary school or the first year of college.
To join the study, participants must be able to read traditional Chinese and understand Cantonese. However, individuals with certain health issues, like a history of photosensitive epilepsy or problems with balance, cannot participate. If eligible, participants can expect to take part in interactive VR sessions that focus on building social skills in a fun and supportive environment. This is an exciting opportunity for young people to enhance their social connections and emotional health as they prepare for the next big step in their education.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 15-19
- • Secondary 6 to college year 1
- • Can read traditional Chinese and understand Cantonese
- Exclusion Criteria:
- • History of photosensitive epilepsy
- • Impairment of stereoscopic vision
- • Balance problems
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sylvia CHEN, Ph.D.
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported